ARTICLE | Company News
Memcine, Spotlight Innovation deal
July 27, 2015 7:00 AM UTC
Spotlight acquired an 82% stake in Memcine, which is developing its Immunoplex vaccine platform technology to use the body’s innate immuno-targeting system to stimulate the immune response following v...